Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related ...

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

Of the scores of day-one executive orders (EOs) issued by President Trump, the order rescinding a Biden administration executive order on ...

The Affordable Care Act (ACA) set out to make healthcare more affordable. It had various effects on Medicare, such as ...

The Trump administration came into office earlier this week with a promise of cutting down on government spending and driving ...

The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...

The Centers for Medicare & Medicaid Services has changed course on plans to appeal a court ruling that determined it must ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

UnitedHealth (UNH) stock in focus as Medicare withdraws appeal over an unfavorable ruling related to the company's 2025-Star ...

Expanding eligibility for MSPs is an important avenue to support health care affordability for older low-income adults, ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.